A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. (Q54534754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Arthur Lyons

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Jenice Longfield

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Robert Kuschner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Timothy Straight

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Leonard Binn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Jitvimol Seriwatana

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Irma B Froh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

David Craft

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kevin McNabb

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kevin Russell

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

David Metzgar

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Alan Liss

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Xiao Sun

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Andrew Towle

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Wellington Sun

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

10 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

number of pages

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

2890-2898

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18448211%20AND%20SRC:MED&resulttype=core&format=json

Recovery of new agent from patients with acute respiratory illness

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Respiratory diseases among U.S. military personnel: countering emerging threats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Adenovirus type 7; 1971-74.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Viruses and disease. 3. An outbreak of adenovirus type 7A in a children's home

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Outbreak of adenovirus 35 pneumonia among adult residents and staff of a chronic care psychiatric facility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Worldwide epidemiology of human adenovirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Live and inactivated adenovirus vaccines. Clinical evaluation of efficacy in prevention of acute respiratory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Epidemic of adenovirus-induced respiratory illness among US military recruits: Epidemiologic and immunologic risk factors in healthy, young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Epidemic spread of adenovirus type 4-associated acute respiratory disease between U.S. Army installations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Large, persistent epidemic of adenovirus type 4-associated acute respiratory disease in U.S. army trainees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Large epidemic of respiratory illness due to adenovirus types 7 and 3 in healthy young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Prevention of adenoviral acute respiratory disease in Army recruits: cost-effectiveness of a military vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Type-specific identification of human adenovirus 3, 7, and 21 by a multiplex PCR assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Identification of subgenus C adenoviruses by fiber-based multiplex PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Rapid type-specific diagnosis of adenovirus type 4 infection using a hexon-based quantitative fluorogenic PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: results of a retrospective nationwide seroprevalence survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Communicability of enteric live adenovirus type 4 vaccine in families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Spread of enteric live adenovirus type 4 vaccine in married couples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Simultaneous Administration of Live, Enteric-Coated Adenovirus Types 4,7, and 21 Vaccines: Safety and Immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

Fatal pneumonia associated with adenovirus type 7 in three military trainees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

7 January 2021

Mass enteric live adenovirus vaccination during epidemic ARD

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

7 January 2021

Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

7 January 2021

Use of A-549 cells in a clinical virology laboratory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

7 January 2021

Alternative cell line for virus isolation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

7 January 2021

Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.037

7 January 2021